Clinical utility of ramucirumab in advanced gastric cancer
Matthew MK Chan,1,2 Katrin M Sjoquist,1,3 John R Zalcberg4 1NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; 2Department of Medical Oncology, Central Coast Cancer Centre, Gosford Hospital, Gosford, NSW, Australia; 3Cancer Care Centre, St George Hospital, Sydney, NSW, Austr...
Guardado en:
Autores principales: | Chan MMK, Sjoquist KM, Zalcberg JR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/753dbcc498084cff88f458d9a9342066 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical utility of ramucirumab in non-small-cell lung cancer
por: Uprety D
Publicado: (2019) -
Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity
por: Cobo M, et al.
Publicado: (2017) -
Clinical utility of targeted treatments in the management of epithelial ovarian cancer
por: Twu C, et al.
Publicado: (2012) -
Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer
por: Thomas Kunzke, et al.
Publicado: (2021) -
Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges
por: Zhi Zhu, et al.
Publicado: (2020)